4.7 Article

Smartphone-Imaged HIV-1 Reverse-Transcription Loop-Mediated Isothermal Amplification (RT-LAMP) on a Chip from Whole Blood

期刊

ENGINEERING
卷 1, 期 3, 页码 324-335

出版社

ELSEVIER SCIENCE BV
DOI: 10.15302/J-ENG-2015072

关键词

human immunodeficiency virus (HIV); viral load; loop-mediated isothermal amplification; smartphone; point-of-care

资金

  1. NIAID NIH HHS [F30 AI109825, R21 AI106024] Funding Source: Medline
  2. Directorate For Engineering
  3. Div Of Chem, Bioeng, Env, & Transp Sys [1264377] Funding Source: National Science Foundation

向作者/读者索取更多资源

Viral load measurements are an essential tool for the long-term clinical care of hum an immunodeficiency virus (HIV)-positive individuals. The gol d standards in viral load instrumentation, however, are still too limited by their size, cost, and sophisticated operation for these measurements to be ubiquitous in remote settings with poor healthcare infrastructure, including parts of the world that are disproportionately affected by HIV infection. The challenge of developing a point-of-care platform capable of making viral load more accessible has been frequently approached but no solution has yet emerged that meets the practical requirements of low cost, portability, and ease-of-use. In this paper, we perform reverse-transcription loop-mediated isothermal amplification (RT-LAMP) on minimally processed HIV-spiked whole blood samples with a microfluidic and silicon microchip platform, and perform fluorescence measurements with a consumer smartphone. Our integrated assay shows amplification from as few as three viruses in a similar to 60 nL RTLAMP droplet, corresponding to a whole blood concentration of 670 viruses per mu L of whole blood. The technology contains greater power in a digital RT-LAMP approach that could be scaled up for the determination of viral load from a finger prick of blood in the clinical care of HIV-positive individuals. We demonstrate that all aspects of this viral load approach, from a drop of blood to imaging the RT-LAMP reaction, are compatible with lab-on-a-chip components and mobile instrumentation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemical Research Methods

A microfluidic biochip platform for electrical quantification of proteins

Enrique Valera, Jacob Berger, Umer Hassan, Tanmay Ghonge, Julia Liu, Michael Rappleye, Jackson Winter, Daniel Abboud, Zeeshan Haidry, Ryan Healey, Na-Teng Hung, Nathaniel Leung, Naif Mansury, Alexander Hasnain, Christine Lannon, Zachary Price, Karen White, Rashid Bashir

LAB ON A CHIP (2018)

Correction Multidisciplinary Sciences

Combining Biomarkers with EMR Data to Identify Patients in Different Phases of Sepsis (vol 7, 10800, 2017)

Ishan Taneja, Bobby Reddy, Gregory Damhorst, Sihai Dave Zhao, Umer Hassan, Zachary Price, Tor Jensen, Tanmay Ghonge, Manish Patel, Samuel Wachspress, Jackson Winter, Michael Rappleye, Gillian Smith, Ryan Healey, Muhammad Ajmal, Muhammad Khan, Jay Patel, Harsh Rawal, Raiya Sarwar, Sumeet Soni, Syed Anwaruddin, Benjamin Davis, James Kumar, Karen White, Rashid Bashir, Ruoqing Zhu

SCIENTIFIC REPORTS (2019)

Article Engineering, Biomedical

Simultaneous electrical detection of IL-6 and PCT using a microfluidic biochip platform

Jacob Berger, Enrique Valera, Aaron Jankelow, Carlos Garcia, Manik Akhand, John Heredia, Tanmay Ghonge, Cynthia Liu, Victor Font-Bartumeus, Gina Oshana, Justin Tiao, Rashid Bashir

BIOMEDICAL MICRODEVICES (2020)

Article Chemistry, Physical

On-Chip Electrical Monitoring of Real-Time Soft and Hard Protein Corona Formation on Carbon Nanoparticles

Indrajit Srivastava, Muhammad S. Khan, Ketan Dighe, Maha Alafeef, Zhen Wang, Tuseeta Banerjee, Tanmay Ghonge, Lauren M. Grove, Rashid Bashir, Dipanjan Pan

SMALL METHODS (2020)

Article Immunology

Current Capabilities of Gut Microbiome-Based Diagnostics and the Promise of Clinical Application

Gregory L. Damhorst, Max W. Adelman, Michael H. Woodworth, Colleen S. Kraft

Summary: There is increasing recognition of the significance of the gut microbiome in human health and disease. Traditional and modern technologies have advanced our knowledge in this field, but standardizing the language and metrics for characterizing the microbiome is still a work in progress. The capabilities of gut microbiome-based diagnostics are promising for clinical applications, with selected examples demonstrating their potential impact.

JOURNAL OF INFECTIOUS DISEASES (2021)

Review Infectious Diseases

Acanthamoeba castellanii encephalitis in a patient with AIDS : a case report and literature review

Gregory L. Damhorst, Abigail Watts, Alfonso Hernandez-Romieu, Nonglin Mel, Melody Palmore, Ibne Karim M. Ali, Stewart G. Neill, Aley Kalapila, Jennifer R. Cope

Summary: This article presents a case of a patient with AIDS who developed Acanthamoeba castellanii encephalitis, a rare cause of central nervous system infection. It highlights the importance for clinicians to consider protozoal infections, specifically free-living amoeba, in immunocompromised patients with CNS infections refractory to traditional antimicrobial therapy.

LANCET INFECTIOUS DISEASES (2022)

Article Biochemical Research Methods

Designing for simplicity: lessons from Mesa Biotech for microfluidic entrepreneurs and early-stage companies

Morgan N. Greenleaf, Gregory L. Damhorst, David N. Ku, Eric J. Nehl, Erika A. Tyburski, Oliver Brand, Greg S. Martin, Wilbur A. Lam

Summary: The COVID-19 pandemic has highlighted the importance of point-of-care diagnosis for respiratory diseases, leading to the rise of microfluidic technology. Mesa Biotech has successfully developed the Accula platform for the diagnosis of various respiratory diseases, including SARS-CoV-2, and has subsequently been acquired by Thermo Fisher for a significant amount. The success of Mesa Biotech can be attributed to their innovative design and engineering choices, which have allowed them to transition from a lab-based product to a commercially successful platform.

LAB ON A CHIP (2022)

Article Immunology

Clinical Utilization of DiaSorin Molecular Polymerase Chain Reaction in Pneumocystis Pneumonia

Gregory L. Damhorst, Kari J. Broder, Elizabeth C. Overton, Ronelio Rara, Lindsay M. Busch, Eileen M. Burd, Andrew S. Webster, Colleen S. Kraft, Ahmed Babiker

Summary: This study retrospectively analyzed the application of Pneumocystis jirovecii PCR and C-T values in the diagnosis and management of Pneumocystis jirovecii pneumonia (PJP). The results showed that PCR testing had high sensitivity and specificity in detecting pathological infection, and the C-T values differed between patients with positive pathology results and those receiving treatment, with high accuracy in predicting positive pathology results.

OPEN FORUM INFECTIOUS DISEASES (2022)

Article Immunology

Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 Infection

Hans P. Verkerke, Gregory L. Damhorst, Daniel S. Graciaa, Kaleb McLendon, William O'Sick, Chad Robichaux, Narayanaiah Cheedarla, Sindhu Potlapalli, Shang Chuen Wu, Kristin R. Harrington, Andrew Webster, Colleen Kraft, Christina A. Rostad, Jesse J. Waggoner, Neel R. Gandhi, Jeannette Guarner, Sara C. Auld, Andrew Neish, John D. Roback, Wilbur A. Lam, N. Sarita Shah, Sean R. Stowell

Summary: In this study, we evaluated SARS-CoV-2 nucleocapsid antigenemia as a marker of acute COVID-19 and investigated outliers to gain a better understanding of the phenomenon. The findings suggest that antigenemia can serve as a biomarker for acute SARS-CoV-2 infection and may have diagnostic utility in various contexts.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Immunology

Nucleocapsid Antigenemia in Patients Receiving Anti-CD20 Therapy With Protracted COVID-19

Eli Wilber, Anne Piantadosi, Ahmed Babiker, Kaleb McLendon, William O'Sick, Eric Fitts, Andrew S. Webster, Hans Verkerke, James S. Kim, Varun K. Phadke, Nadine Rouphael, Boghuma K. Titanji, William T. Blake, Jessica Howard-Anderson, John D. Roback, Wilbur A. Lam, Gregory L. Damhorst

Summary: Immunocompromised patients with prolonged coronavirus disease 2019 symptoms present diagnostic and therapeutic challenges. Nucleocapsid antigenemia can serve as a marker for persistent infection and therapeutic response in these patients, especially those treated with anti-CD20 immunotherapy.

OPEN FORUM INFECTIOUS DISEASES (2022)

Article Computer Science, Hardware & Architecture

A 56-Gb/s Long-Reach Fully Adaptive Wireline PAM-4 Transceiver in 7-nm FinFET

Dirk Pfaff, Shahaboddin Moazzeni, Leisheng Gao, Mei-Chen Chuang, Xin-Jie Wang, Chai Palusa, Robert Abbott, Rolando Ramirez, Maher Amer, Ming-Chieh Huang, Chih-Chang Lin, Fred Kuo, Wei-Li Chen, Tae Young Goh, Kenny Hsieh

IEEE SOLID-STATE CIRCUITS LETTERS (2019)

Review Engineering, Biomedical

Diagnosis of acute serious illness: the role of point-of-care technologies

Gregory L. Damhorst, Erika A. Tyburski, Oliver Brand, Greg S. Martin, Wilbur A. Lam

CURRENT OPINION IN BIOMEDICAL ENGINEERING (2019)

Meeting Abstract Chemistry, Multidisciplinary

Real-time monitoring of soft and hard protein corona in carbon dots via a microfluidic setup

Indrajit Srivastava, Muhammad Khan, Ketan Dighe, Tanmay Ghonge, Lauren Grove, Dipanjan Pan

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY (2019)

Article Chemistry, Analytical

Smartphone-imaged microfluidic biochip for measuring CD64 expression from whole blood

Tanmay Ghonge, Hatice Ceylan Koydemir, Enrique Valera, Jacob Berger, Carlos Garcia, Noshin Nawar, Justin Tiao, Gregory L. Damhorst, Anurup Ganguli, Umer Hassan, Aydogan Ozcan, Rashid Bashir

ANALYST (2019)

暂无数据